BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30963224)

  • 1. [Anti-laminin 332 mucous membrane pemphigoid with irreversible ocular and tracheobronchial involvement : Delayed diagnosis of a severe autoimmune bullous disease].
    Syring FM; Zillikens D; Schmidt E; Kasperkiewicz M
    Hautarzt; 2019 May; 70(5):367-370. PubMed ID: 30963224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA.
    Bekou V; Thoma-Uszynski S; Wendler O; Uter W; Schwietzke S; Hunziker T; Zouboulis CC; Schuler G; Sorokin L; Hertl M
    J Invest Dermatol; 2005 Apr; 124(4):732-40. PubMed ID: 15816831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies.
    Chan LS; Yancey KB; Hammerberg C; Soong HK; Regezi JA; Johnson K; Cooper KD
    Arch Dermatol; 1993 Apr; 129(4):448-55. PubMed ID: 7682049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
    Raffin D; Delaplace M; Roussel A; Estève E
    Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5.
    Kirtschig G; Marinkovich MP; Burgeson RE; Yancey KB
    J Invest Dermatol; 1995 Oct; 105(4):543-8. PubMed ID: 7561156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
    Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
    JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
    Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
    J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5.
    Kawahara Y; Amagai M; Ohata Y; Ishii K; Hasegawa Y; Hsu R; Yee C; Yancey KB; Nishikawa T
    J Am Acad Dermatol; 1998 Apr; 38(4):624-7. PubMed ID: 9555805
    [No Abstract]   [Full Text] [Related]  

  • 9. Ocular 'non-scarring' mucous membrane pemphigoid associated with anti-laminin-5 antibodies.
    Coronella G; Amato L; Berti S; Moretti S; Terracina M; Mastrogiacomo A; Fabbri P
    Clin Exp Dermatol; 2005 Nov; 30(6):679-81. PubMed ID: 16197388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-p200/anti-laminin γ1 pemphigoid and BP180 NC16A/4575- positive mucous membrane pemphigoid : late diagnosis in a patient with disease-related loss of vision and multiple previous surgical interventions].
    Kaune KM; Kasperkiewicz M; Tams D; Bergmann M; Zutt M
    Hautarzt; 2015 Jan; 66(1):60-4. PubMed ID: 25339385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inflammatory desquamative dermatosis of the ear with anti-180 kDa antibodies: localized cicatricial pemphigoid?
    Drummond A; Gupta G; Swan IR; Thomson J
    Br J Dermatol; 2000 Apr; 142(4):815-6. PubMed ID: 10792241
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of mucous membrane pemphigoid with anti-laminin alpha 3 and beta 3 antibodies initially mimicking Stevens-Johnson syndrome.
    Sugawara A; Koga H; Tsutsumi M; Ishii N; Nakama T
    Int J Dermatol; 2022 Jun; 61(6):e199-e200. PubMed ID: 34196975
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics Associated With Refractory Course, Blindness, and Treatment Strategy-Related Outcomes in Patients With Mucous Membrane Pemphigoid.
    Kridin K; van Beek N; Bühler E; Kochan AS; Ranjbar M; Beissert S; Zillikens D; Günther C; Schmidt E
    JAMA Dermatol; 2023 Feb; 159(2):198-203. PubMed ID: 36630148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?
    Leverkus M; Schmidt E; Lazarova Z; Bröcker EB; Yancey KB; Zillikens D
    Arch Dermatol; 1999 Sep; 135(9):1091-8. PubMed ID: 10490114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of bullous pemphigoid and mucous membrane pemphigoid].
    Kern JS; Hofmann SC
    Dermatologie (Heidelb); 2022 Dec; 74(12):927-936. PubMed ID: 37843581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-p200 pemphigoid: a spectacular response to dapsone].
    Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
    Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid.
    Chiorean R; Danescu S; Virtic O; Mustafa MB; Baican A; Lischka A; Hashimoto T; Kariya Y; Koch M; Sitaru C
    Orphanet J Rare Dis; 2018 Jul; 13(1):111. PubMed ID: 29980216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects of ocular mucosal pemphigoid].
    Roth M; Yaici R; Geerling G
    Ophthalmologie; 2023 May; 120(5):472-477. PubMed ID: 37095414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case of mucous membrane pemphigoid with immunoglobulin G antibodies to the beta 3 subunit of laminin-332 showing clinically Stevens-Johnson syndrome-like generalized blistering mucocutaneous lesions.
    Murata S; Sumikawa Y; Takahashi H; Ota M; Kusatake K; Niihara H; Kaneko S; Koga H; Hashimoto T; Morita E
    J Dermatol; 2015 Nov; 42(11):1126-8. PubMed ID: 26299201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.